Michael J. Fox Foundation Launches Target Validation Program for Parkinson’s Therapies
The Michael J. Fox Foundation for Parkinson’s Research has begun funding its first target validation projects under the multi-year Targets to Therapies Initiative, focusing on biological targets such as NOD2, OGA, and TRPML1 to advance new Parkinson’s treatments.